TL 383 TL 383 (Terazosin 1 mg)

Pill imprint TL 383 TL 383 has been identified as Terazosin hydrochloride 1 mg.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 1 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for TL 383 TL 383

Terazosin hydrochloride 1 mg TL 383 TL 383
Terazosin hydrochloride 1 mg TL 383 TL 383
Terazosin hydrochloride
Imprint:
TL 383
TL 383
Strength:
1 mg
Color:
Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Cadista
National Drug Code (NDC):
59746-0383
Inactive Ingredients:
ferrosoferric oxide
gelatin
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
corn starch
silicon dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
67544-0581 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)